SUPERNUS PHARMACEUTICALS, INC.·4

Feb 24, 5:16 PM ET

SIEBERT JOHN M 4

4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 24, 2023

Insider Transaction Report

Form 4
Period: 2023-02-22
Transactions
  • Disposition to Issuer

    Restricted Stock Units

    2023-02-223,8820 total
    Common Stock (3,882 underlying)
  • Award

    Common Stock

    2023-02-22+3,88284,057 total
Footnotes (2)
  • [F1]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
  • [F2]These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2023.

Documents

1 file
  • 4
    tm237737-5_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT